Combination of the pro-inflammatory cytokines IL-1, TNF-α and IL-17 leads to enhanced expression and additional recruitment of AP-1 family members, Egr-1 and NF-κB in osteoblast-like cells

Cytokine

Volumn 26, Issue 4, 2004, Pages 169-177

  Granet, Corinne ^a   Miossec, Pierre ^a  

^a EDOUARD HERRIOT HOSPITAL   (France)

Author keywords

Osteoblasts; Pro inflammatory cytokines; Rheumatoid arthritis; Transcription factors

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 17; PROTEIN C JUN; PROTEIN FOS; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR EGR 1; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; OSSIFICATION; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; DNA-BINDING PROTEINS; EARLY GROWTH RESPONSE PROTEIN 1; IMMEDIATE-EARLY PROTEINS; INTERLEUKIN-1; INTERLEUKIN-17; JNK MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; OSTEOBLASTS; PROTEIN TRANSPORT; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RNA, MESSENGER; TRANSCRIPTION FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 2442621078     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2004.03.002     Document Type: Article

References (40)

1. Manolagas S.C. Role of cytokines in bone resorption. Bone. 17:1995;63S-67S
2. Lader C.S., Flanagan A.M. Prostaglandin E2, interleukin-1a, and tumor necrosis factor-a, increase human osteoblast formation and bone resorption in vitro. Endocrinology. 139:1998;3157-3164
3. Kelliher M.A., Grimm S., Ishida Y., Kuo F., Stanger B.Z., Leder P. The death domain kinase RIP mediates the TNF-induced NF-kappaB signal. Immunity. 8:1998;297-303
4. Baud V., Liu Z.G., Bennett B., Suzuki N., Xia Y., Karin M. Signalling by proinflammatory cytokines: oligomerization of TRAF2 and TRAF6 is sufficient for JNK and IKK activation and target gene induction via an amino-terminal effector domain. Genes Dev. 13:1999;1297-1308
5. Arend W.P. The mode of action of cytokine inhibitors. J Rheumatol. 65:2002;16-21
6. Van den Berg W.B. Lessons from animal models of arthritis. Curr Rheumatol Rep. 4:2002;232-239
7. Chabaud M., Durand J.M., Buchs N., Fossiez F., Page G., Frappart L., et al. Human interleukin-17: a T cell-derived proinflammatory cytokine produced by the rheumatoid synovium. Arthritis Rheum. 42:1999;963-970
8. Chabaud M., Lubberts E., Joosten L., van Den Berg W., Miossec P. IL-17 derived from juxta-articular bone and synovium contributes to joint degradation in rheumatoid arthritis. Arthritis Res. 3:2001;168-177
9. Kehlen A., Thiele K., Riemann D., Langner J. Expression, modulation and signalling of IL-17 receptor in fibroblast-like synoviocytes of patients with rheumatoid arthritis. Clin Exp Immunol. 127:2002;539-546
10. Fossiez F., Djossou O., Chomarat P., Flores-Romo L., Ait-Yahia S., Maat C., et al. T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J Exp Med. 183:1996;2593-2603
11. Shalom-Barak T., Quach J., Lotz M. Interleukin-17-induced gene expression in articular chondrocytes is associated with activation of mitogen-activated protein kinases and NF-kappaB. J Biol Chem. 273:1998;27467-27473
12. Chabaud M., Fossiez F., Taupin J.L., Miossec P. Enhancing effect of IL-17 on IL-1-induced IL-6 and leukemia inhibitory factor production by rheumatoid arthritis synoviocytes and its regulation by Th2 cytokines. J Immunol. 161:1998;409-414
13. Chabaud M., Garnero P., Dayer J.M., Guerne P.A., Fossiez F., Miossec P. Contribution of interleukin 17 to synovium matrix destruction in rheumatoid arthritis. Cytokine. 12:2000;1092-1099
14. Katz Y., Nadiv O., Beer Y. Interleukin-17 enhances tumor necrosis factor alpha-induced synthesis of interleukins 1, 6, and 8 in skin and synovial fibroblasts: a possible role as a "fine-tuning cytokine" in inflammation processes. Arthritis Rheum. 44:2001;2176-2184
15. Chabaud M., Miossec P. The combination of tumor necrosis factor alpha blockade with interleukin-1 and interleukin-17 blockade is more effective for controlling synovial inflammation and bone resorption in an ex vivo model. Arthritis Rheum. 44:2001;1293-1303
16. LeGrand A., Fermor B., Fink C., Pisetsky D.S., Weinberg J.B., Vail T.P., et al. Interleukin-1, tumor necrosis factor alpha, and interleukin-17 synergistically up-regulate nitric oxide and prostaglandin E2 production in explants of human osteoarthritic knee menisci. Arthritis Rheum. 44:2001;2078-2083
17. Tak P.P., Firestein G.S. NF-kappaB: a key role in inflammatory diseases. J Clin Invest. 107:2001;7-11
18. Han Z., Boyle D.L., Manning A.M., Firestein G.S. AP-1 and NF-kappaB regulation in rheumatoid arthritis and murine collagen-induced arthritis. Autoimmunity. 28:1998;197-208
19. Firestein G.S., Manning A.M. Signal transduction and transcription factors in rheumatic diseases. Arthritis Rheum. 42:1999;609-621
20. Grimbacher B., Aicher W.K., Peter H.H., Eibel H. Measurement of transcription factor c-fos and EGR-1 mRNA transcription levels in synovial tissue by quantitative RT-PCR. Rheumatol Int. 17:1997;109-112
21. Asahara H., Fujisawa K., Kobata T., Hasunuma T., Maeda T., Asanuma M., et al. Direct evidence of high DNA binding activity of transcription factor AP-1 in rheumatoid arthritis synovium. Arthritis Rheum. 40:1997;912-918
22. Wakisaka S., Suzuki N., Takeno M., Takeba Y., Nagafuchi H., Saito N., et al. Involvement of simultaneous multiple transcription factor expression, including cAMP responsive element binding protein and OCT-1, for synovial cell outgrowth in patients with rheumatoid arthritis. Ann Rheum Dis. 57:1998;487-494
23. Lin J.X., Vilcek J. Tumor necrosis factor and interleukin-1 cause a rapid and transient stimulation of c-fos and c-myc mRNA levels in human fibroblasts. J Biol Chem. 262:1987;11908-11911
24. Guy G.R., Cao X., Chua S.P., Tan Y.H. Okadaic acid mimics multiple changes in early protein phosphorylation and gene expression induced by tumor necrosis factor or interleukin-1. J Biol Chem. 267:1992;1846-1852
25. Goldring M.B., Birkhead J.R., Suen L.F., Yamin R., Mizuno S., Glowacki J., et al. Interleukin-1 beta-modulated gene expression in immortalized human chondrocytes. J Clin Invest. 94:1994;2307-2316
26. Aupperle K.R., Bennett B.L., Boyle D.L., Tak P.P., Manning A.M., Firestein G.S. NF-kappa B regulation by I kappa B kinase in primary fibroblast-like synoviocytes. J Immunol. 163:1999;427-433
27. Suzuki M., Tetsuka T., Yoshida S., Watanabe N., Kobayashi M., Matsui N., et al. The role of p38 mitogen-activated protein kinase in IL-6 and IL-8 production from the TNF-alpha- or IL-1beta-stimulated rheumatoid synovial fibroblasts. FEBS Lett. 465:2000;23-27
28. Georganas C., Liu H., Perlman H., Hoffmann A., Thimmapaya B., Pope R.M. Regulation of IL-6 and IL-8 expression in rheumatoid arthritis synovial fibroblasts: the dominant role for NF-kappa B but not C/EBP beta or c-Jun. J Immunol. 165:2000;7199-7206
29. Trabandt A., Aicher W.K., Gay R.E., Sukhatme V.P., Fassbender H.G., Gay S. Spontaneous expression of immediately-early response genes c-fos and egr-1 in collagenase-producing rheumatoid synovial fibroblasts. Rheumatol Int. 12:1992;53-59
30. Cao X.M., Guy G.R., Sukhatme V.P., Tan Y.H. Regulation of the Egr-1 gene by tumor necrosis factor and interferons in primary human fibroblasts. J Biol Chem. 267:1992;1345-1349
31. Grimbacher B., Aicher W.K., Peter H.H., Eibel H. TNF-alpha induces the transcription factor Egr-1, pro-inflammatory cytokines and cell proliferation in human skin fibroblasts and synovial lining cells. Rheumatol Int. 17:1998;185-192
32. Van Bezooijen R.L., Van Der Wee-Pals L., Papapoulos S.E., Lowik C.W. Interleukin 17 synergises with tumour necrosis factor alpha to induce cartilage destruction in vitro. Ann Rheum Dis. 61:2002;870-876
33. Van Bezooijen R.L., Papapoulos S.E., Lowik C.W. Effect of interleukin-17 on nitric oxide production and osteoclastic bone resorption: is there dependency on nuclear factor-kappaB and receptor activator of nuclear factor kappaB (RANK)/RANK ligand signalling? Bone. 28:2001;378-386
34. Kotake S., Udagawa N., Takahashi N., Matsuzaki K., Itoh K., Ishiyama S., et al. IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J Clin Invest. 103:1999;1345-1352
35. Benderdour M., Tardif G., Pelletier J.P., Di Battista J.A., Reboul P., Ranger P., et al. Interleukin 17 (IL-17) induces collagenase-3 production in human osteoarthritic chondrocytes via AP-1 dependent activation: differential activation of AP-1 members by IL-17 and IL-1beta. J Rheumatol. 29:2002;1262-1272
36. Schwandner R., Yamaguchi K., Cao Z. Requirement of tumor necrosis factor receptor-associated factor (TRAF)6 in interleukin 17 signal transduction. J Exp Med. 191:2000;1233-1240
37. Awane M., Andres P.G., Li D.J., Reinecker H.C. NF-kappa B-inducing kinase is a common mediator of IL-17-, TNF-alpha-, and IL-1 beta-induced chemokine promoter activation in intestinal epithelial cells. J Immunol. 162:1999;5337-5344
38. Andoh A., Takaya H., Makino J., Sato H., Bamba S., Araki Y., et al. Cooperation of interleukin-17 and interferon-gamma on chemokine secretion in human fetal intestinal epithelial cells. Clin Exp Immunol. 125:2001;56-63
39. Chevrel G., Page G., Granet C., Streichenberger N., Varennes A., Miossec P. Interleukin-17 increases the effects of IL-1 beta on muscle cells: arguments for the role of T cells in the pathogenesis of myositis. J Neuroimmunol. 137:2003;125-133
40. Majeska R.J., Rodan G.A. Alkaline phosphatase inhibition by parathyroid hormone and isoproterenol in a clonal rat osteosarcoma cell line. Possible mediation by cyclic AMP. Calcif Tissue Int. 34:1982;59-66